Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duchenne Muscular Dystrophy Quality of Life: Qualitative Interviews With Patients and Caregivers

NCT06925269 is registered in ClinicalTrials.gov with Red Nucleus Enterprise Solutions, LLC as lead sponsor.

NCT NCT06925269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06925269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duchenne Muscular Dystrophy Quality of Life: Qualitative Interviews With Patients and Caregivers
Lead sponsor
Red Nucleus Enterprise Solutions, LLC
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2025
Completion date
December 31, 2026
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy (dmd)